US based COBRA diagnostic prostate cancer trial reaches recruitment target

/PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products...

Related Keywords

United States ,Sydney ,New South Wales ,Australia ,American ,Alan Taylor ,Clarity Pharmaceuticals ,American Cancer Institute ,Technology Platform ,Carolina Urologic Research Centre ,Prnewswire Clarity Pharmaceuticals ,American Cancer Society ,Biochemically Recurrent ,Emission Tomography ,Principal Investigator ,Surgical Oncology ,Medical Director ,Executive Chairman ,Targeted Copper Theranostic ,Targeted Copper Theranostics ,Cancer Statistics ,Mortality Worldwide ,Cancer Society ,Key Statistics ,Prostate Cancer ,